Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Cystic Fibrosis Therapeutics Market
Cystic Fibrosis Therapeutics Market Size
- Report ID: GMI5118
- Published Date: Sep 2021
- Report Format: PDF
Cystic Fibrosis Therapeutics Market Size
Cystic Fibrosis Therapeutics Market size exceeded USD 8.5 billion in 2020 and is anticipated to grow at over 16.1% CAGR from 2021 to 2027. Growing awareness about the potential threat of cystic fibrosis, rise in the adoption of drug therapies and increasing prevalence of cystic fibrosis across the globe, are some of the prominent factors that drive the market growth. There was no considerable impact of COVID-19 on the cystic fibrosis therapeutics industry, since several countries adopted lockdown and cancelled routine clinic appointments to prevent unnecessary hospital visits and viral spread. The market witnessed a short-term disruption during the initial days of the COVID-19 pandemic due to decline in non-urgent in-person clinic visits.
| Report Attribute | Details |
|---|---|
| Base Year: | 2020 |
| Cystic Fibrosis Therapeutics Market Size in 2020: | USD 8.6 Billion |
| Forecast Period: | 2021 to 2027 |
| Forecast Period 2021 to 2027 CAGR: | 16.1% |
| 2027 Value Projection: | USD 26.7 Billion |
| Historical Data for: | 2016 to 2020 |
| No. of Pages: | 100 |
| Tables, Charts & Figures: | 96 |
| Segments covered: | Treatment Method, Distribution Channel, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Cystic Fibrosis Therapeutics Market Scope
